Literature DB >> 9553186

Timing of colonic necrosis in hemolytic uremic syndrome.

D A Saltzman1, B Chavers, W Brennom, R Vernier, R L Telander.   

Abstract

Hemolytic uremic syndrome (HUS) consists of an acute onset of microangiopathic hemolytic anemia, thrombocytopenia, and renal dysfunction. HUS-associated colitis can be seen in up to 100% of patients and is usually associated with severe abdominal pain and distention. Colonic perforation is a complication of HUS that has a reported incidence of 1%-2%, and although there are several case reports in the literature describing perforation of the colon, it is still very difficult to discern the abdominal symptoms associated with HUS colitis from perforation. Four cases of colonic perforation are reported here from a consecutive series of 57 patients, in which a trend in the length of time from the onset of symptoms of HUS to colonic perforation was determined. A review of the literature for cases of HUS-associated colonic perforation was also performed. The time from the onset of HUS symptoms to colonic perforation in our series was similar to that found in the literature review (11 +/- 5 vs 14 +/- 8 days). Awareness that this complication has a tendency to occur towards the end of the 2nd week during the course of HUS is essential to avoid an unnecessary and untimely surgical intervention.

Entities:  

Mesh:

Year:  1998        PMID: 9553186     DOI: 10.1007/s003830050313

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  2 in total

1.  Gram-negative organisms in peritoneal dialysis peritonitis: an early indication for surgery in patients with haemolytic uraemic syndrome?

Authors:  Rachel Harwood; David Wilkinson; Shweta Ramkumar; Gillian Humphrey
Journal:  Pediatr Surg Int       Date:  2015-11-17       Impact factor: 1.827

2.  Clinical aspects of a nationwide epidemic of severe haemolytic uremic syndrome (HUS) in children.

Authors:  Lars Krogvold; Thore Henrichsen; Anna Bjerre; Damien Brackman; Henrik Dollner; Helga Gudmundsdottir; Gaute Syversen; Pål Aksel Næss; Hans Jacob Bangstad
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2011-07-28       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.